검색어 : 통합검색[Coombs Timothy]
총 160건 중 160건 출력
, 16/16 페이지
-
151
- Poster: MCL-133 Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results From the Phase 1/2 BRUIN Study
- Cohen, Jonathon B.; Shah, Nirav N.; Alencar, Alvaro J.; Gerson, James N.; Patel, Manish R.; Fakhri, Bita; Jurczak, Wojciech; Tan, Xuan Ni; Lewis, Katharine L.; Fenske, Timothy; Coombs, Catherine C.; Flinn, Ian W.; Lewis, David J.; Gouill, Steven Le; Palomba, M. Lia; Woyach, Jennifer A.; Pagel, John M.; Lamanna, Nicole; Barve, Minal A.; Ghia, Paolo; Eyre, Toby A.; Zinzani, Pier Luigi; Ujjani, Chaitra S.; Koh, Youngil; Izutsu, Koji; Lech-Maranda, Ewa; Tam, Constantine S.; Sundaram, Suchitra; Yin, Ming; Nair, Binoj; Tsai, Donald E.; Balbas, Minna; Mato, Anthony R.; Cheah, Chan Y.; Wang, Michael L.; ; (Clinical lymphoma, myeloma & leukemia, v.22, 2022, pp.S175)
-
152
- Oral Abstract: MCL-133 Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results From the Phase 1/2 BRUIN Study
- Cohen, Jonathon B.; Shah, Nirav N.; Alencar, Alvaro J.; Gerson, James N.; Patel, Manish R.; Fakhri, Bita; Jurczak, Wojciech; Tan, Xuan Ni; Lewis, Katharine L.; Fenske, Timothy; Coombs, Catherine C.; Flinn, Ian W.; Lewis, David J.; Gouill, Steven Le; Palomba, M. Lia; Woyach, Jennifer A.; Pagel, John M.; Lamanna, Nicole; Barve, Minal A.; Ghia, Paolo; Eyre, Toby A.; Zinzani, Pier Luigi; Ujjani, Chaitra S.; Koh, Youngil; Izutsu, Koji; Lech-Maranda, Ewa; Tam, Constantine S.; Sundaram, Suchitra; Yin, Ming; Nair, Binoj; Tsai, Donald E.; Balbas, Minna; Mato, Anthony R.; Cheah, Chan Y.; Wang, Michael L.; ; (Clinical lymphoma, myeloma & leukemia, v.22, 2022, pp.S118)
-
153
- MCL-133 Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results From the Phase 1/2 BRUIN Study
- Cohen, Jonathon B.; Shah, Nirav N.; Alencar, Alvaro J.; Gerson, James N.; Patel, Manish R.; Fakhri, Bita; Jurczak, Wojciech; Tan, Xuan Ni; Lewis, Katharine L.; Fenske, Timothy; Coombs, Catherine C.; Flinn, Ian W.; Lewis, David J.; Gouill, Steven Le; Palomba, M. Lia; Woyach, Jennifer A.; Pagel, John M.; Lamanna, Nicole; Barve, Minal A.; Ghia, Paolo; Eyre, Toby A.; Zinzani, Pier Luigi; Ujjani, Chaitra S.; Koh, Youngil; Izutsu, Koji; Lech-Maranda, Ewa; Tam, Constantine S.; Sundaram, Suchitra; Yin, Ming; Nair, Binoj; Tsai, Donald E.; Balbas, Minna; Mato, Anthony R.; Cheah, Chan Y.; Wang, Michael L.; ; (Clinical lymphoma, myeloma & leukemia, v.22, 2022, pp.S394-S395)
-
154
- Pirtobrutinib, A Next Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results from the Phase 1/2 BRUIN Study
- Wang, Michael; Shah, Nirav N.; Alencar, Alvaro J.; Gerson, James N.; Patel, Manish R.; Fakhri, Bita; Jurczak, Wojciech; Tan, Xuan Ni; Lewis, Katharine; Fenske, Timothy S.; Coombs, Catherine C.; Flinn, Ian W.; Lewis, David John; Le Gouill, Steven; Palomba, M. Lia; Woyach, Jennifer A.; Pagel, John M.; Lamanna, Nicole; Cohen, Jonathon B.; Barve, Minal A.; Ghia, Paolo; Eyre, Toby A.; Zinzani, Pier Luigi Luigi; Ujjani, Chaitra S.; Koh, Youngil; Izutsu, Koji; Lech-Marań da, Ewa; Tam, Constantine S.; Sundaram, Suchitra; Yin, Ming; Nair, Binoj; Balbas, Minna; Tsai, Donald; Mato, Anthony R.; Cheah, Chan Yoon; University of Texas MD Anderson Cancer Center, Houston, TX; Medical College of Wisconsin, Milwaukee, WI; Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL; University of California San Francisco, San Francisco, CA; UJ CM, Krakow, Poland; Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Australia; Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, Australia; Medical College of Wisconsin, Milwaukee, WI; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC; Sarah Cannon Research Institute, Nashville, TN; University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom; Service d'hé matologie clinique du CHU de Nantes, INSERM CRCINA Nantes-Angers, NeXT Université de Nantes, Nantes, France; D; (Blood, v.138, 2021, pp.381-381)
-
155
- Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
- Mato, Anthony R; Shah, Nirav N; Jurczak, Wojciech; Cheah, Chan Y; Pagel, John M; Woyach, Jennifer A; Fakhri, Bita; Eyre, Toby A; Lamanna, Nicole; Patel, Manish R; Alencar, Alvaro; Lech-Maranda, Ewa; Wierda, William G; Coombs, Catherine C; Gerson, James N; Ghia, Paolo; Le Gouill, Steven; Lewis, David John; Sundaram, Suchitra; Cohen, Jonathon B; Flinn, Ian W; Tam, Constantine S; Barve, Minal A; Kuss, Bryone; Taylor, Justin; Abdel-Wahab, Omar; Schuster, Stephen J; Palomba, M Lia; Lewis, Katharine L; Roeker, Lindsey E; Davids, Matthew S; Tan, Xuan Ni; Fenske, Timothy S; Wallin, Johan; Tsai, Donald E; Ku, Nora C; Zhu, Edward; Chen, Jessica; Yin, Ming; Nair, Binoj; Ebata, Kevin; Marella, Narasimha; Brown, Jennifer R; Wang, Michael; ; (The Lancet, v.397, 2021, pp.892-901)
-
156
- THE SEROLOGICAL EXAMINATION OF SERA FROM NORMAL PERSONS AND FROM HAYFEVER PATIENTS BOTH BEFORE AND AFTER SPECIFIC HYPOSENSITIZATION FOR HEATSTABLE ANTIBODIES TO THE PROTEINS OF TIMOTHY GRASS POLLEN
- BRITTON, C. J. C.; COOMBS, R. R. A.; ; (Acta allergologica, v.8, 1955, pp.31-43)
-
157
- Changes in HIV-1 Subtypes B and C Genital Tract RNA in Women and Men After Initiation of Antiretroviral Therapy
- Fiscus, Susan A.; Cu-Uvin, Susan; Eshete, Abel Tilahun; Hughes, Michael D.; Bao, Yajing; Hosseinipour, Mina; Grinsztejn, Beatriz; Badal-Faesen, Sharlaa; Dragavon, Joan; Coombs, Robert W.; Braun, Ken; Moran, Laura; Hakim, James; Flanigan, Timothy; Kumarasamy, N.; Campbell, Thomas B.; Klingman, Karin L.; Nair, Apsara; Walawander, Ann; Smeaton, Laura M.; De Gruttola, Victor; Martinez, Ana I.; Swann, Edith; Barnett, Ronald L.; Brizz, Barbara; Delph, Yvette; Gettinger, Nikki; Mitsuyasu, Ronald T.; Eshleman, Susan; Safren, Steven; Andrade, Adriana; Haas, David W.; Amod, Farida; Berthaud, Vladimir; Bollinger, Robert C.; Bryson, Yvonne; Celentano, David; Chilongozi, David; Cohen, Myron; Collier, Ann C.; Currier, Judith Silverstein; Eron, Joseph; Firnhaber, Cynthia; Flexner, Charles; Gallant, Joel E.; Gulick, Roy M.; Hammer, Scott M.; Hoffman, Irving; Kazembe, Peter; Kumwenda, Johnstone; Kumwenda, Newton; Lama, Javier R.; Lawrence, Jody; Mapo; University of North Carolina at Chapel Hill; Brown University, Providence, Rhode Island; Harvard School of Public Health, Boston, Massachusetts; Harvard School of Public Health, Boston, Massachusetts; Harvard School of Public Health, Boston, Massachusetts; UNC Project, Lilongwe, Malawi; Instituto de Pesquisa Clinica Evandro Chagas, Rio de Janeiro, Brazil; University of Witwatersrand, Johannesburg, South Africa; University of Washington, Seattle; University of Washington, Seattle; Frontier Science and Research Technology Foundation, Amherst, New York; Social and Scientific Systems, Silver Spring, Maryland; University of Zimbabwe, Harare; Brown University, Providence, Rhode Island; YRG Centre for AIDS Research, Chennai, India; University of Colorado Denver, Aurora; (Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, v.57, 2013, pp.290-297)
-
158
- Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular Therapies
- Mato, Anthony R.; Roeker, Lindsey E.; Eyre, Toby A.; Jacobs, Ryan; Hill, Brian T.; Lamanna, Nicole; Brander, Danielle M.; Shadman, Mazyar; Ujjani, Chaitra; Yazdy, Maryam; Perini, Guilherme Fleury; Pinilla Ibarz, Javier; Barrientos, Jacqueline C; Skarbnik, Alan; Torka, Pallawi; Pu, Jeffrey J; Pagel, John M.; Gohil, Satyen; Fakhri, Bita; Choi, Michael Y.; Coombs, Catherine C.; Rhodes, Joanna; Barr, Paul M.; Portell, Craig A.; Parry, Helen; Garcia, Christine Ann; Whitaker, Kate J; Winter, Allison M.; Sitlinger, Andrea; Khajavian, Sirin; Grajales-Cruz, Ariel F; Isaac, Krista; Shah, Pratik; Akhtar, Othman S.; Pocock, Rachael; Lam, Kentson; Voorhees, Timothy J; Schuster, Stephen J.; Rodgers, Thomas David; Martinez-Calle, Nicolas; Munir, Talha; Bhavsar, Erica B; Bailey, Neil; Lee, Jason C.; Weissbrot, Hanna; Nabhan, Chadi; Goodfriend, Julie; King, Amber C.; Zelenetz, Andrew D.; Dorsey, Colleen; Bigelow, Kayla; Cheson, Bruce D.; Fox, Christop; Memorial Sloan Kettering Cancer Center, New York, NY; Memorial Sloan Kettering Cancer Center, New York, NY; Department of Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, HP11 2TJ, United Kingdom; Department of Hematology, Lymphoma Division, Levine Cancer Institute, Charlotte, NC; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH; Herbert Irving Comprehensive Cancer Center (New York-Presbyterian Columbia University Medical Center), New York, NY; Duke University Medical Center, Durham, NC; Fred Hutchinson Cancer Research Center, Seattle, WA; Seattle Cancer Care Alliance/Fred Hutchinson Cancer Research Center, Seattle,; Georgetown University Hospital Lombardi Comprehensive Cancer Center, Washington, DC; Hospital Israelita Albert Einstein, Sao Paulo, Brazil; Division of Malignant Hematology, Moffitt Cancer Center, Tampa, FL; North Shore University Hospital, Northwell Health, Man; (Blood, v.134, 2019, pp.502-502)
-
159
- Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy
- Mato, Anthony R.; Roeker, Lindsey E.; Jacobs, Ryan; Hill, Brian T.; Lamanna, Nicole; Brander, Danielle; Shadman, Mazyar; Ujjani, Chaitra S.; Yazdy, Maryam Sarraf; Perini, Guilherme Fleury; Pinilla-Ibarz, Javier A.; Barrientos, Jacqueline; Skarbnik, Alan P.; Torka, Pallawi; Pu, Jeffrey J.; Pagel, John M.; Gohil, Satyen; Fakhri, Bita; Choi, Michael; Coombs, Catherine C.; Rhodes, Joanna; Barr, Paul M.; Portell, Craig A.; Parry, Helen; Garcia, Christine A.; Whitaker, Kate J.; Winter, Allison M.; Sitlinger, Andrea; Khajavian, Sirin; Grajales-Cruz, Ariel F.; Isaac, Krista M.; Shah, Pratik; Akhtar, Othman S.; Pocock, Rachael; Lam, Kentson; Voorhees, Timothy J.; Schuster, Stephen J.; Rodgers, Thomas D.; Fox, Christopher P.; Martinez-Calle, Nicolas; Munir, Talha; Bhavsar, Erica B.; Bailey, Neil; Lee, Jason C.; Weissbrot, Hanna B.; Nabhan, Chadi; Goodfriend, Julie M.; King, Amber C.; Zelenetz, Andrew D.; Dorsey, Colleen; Bigelow, Kayla; Cheson,; Memorial Sloan Kettering Cancer Center, New York, New York.; Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Hematology, Lymphoma Division, Levine Cancer Institute, Charlotte, North Carolina.; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio.; Herbert Irving Comprehensive Cancer Center (New York-Presbyterian Columbia University Medical Center), New York, New York.; Duke University Medical Center, Durham, North Carolina.; Fred Hutchinson Cancer Research Center, Seattle, Washington.; Seattle Cancer Care Alliance/Fred Hutchinson Cancer Research Center, Seattle, Washington.; Georgetown University Hospital Lombardi Comprehensive Cancer Center, Washington D.C.; Hospital Israelita Albert Einstein, Sao Paulo, Pará , Brazil.; Division of Malignant Hematology, Moffitt Cancer Center, Tampa, Florida.; North Shore University Hospital, Northwell Health, Manhasset, New York.; Novant Healt; (Clinical Cancer research : an official journal of the American Association for Cancer Research, v.26, 2020, pp.3589-3596)
-
160
- Description of outcomes of experimental infection with feline haemoplasmas: Copy numbers, haematology, Coombs’ testing and blood glucose concentrations
- Tasker, Sé verine; Peters, Iain R.; Papasouliotis, Kostas; Cue, Simon M.; Willi, Barbara; Hofmann-Lehmann, Regina; Gruffydd-Jones, Timothy J.; Knowles, Toby G.; Day, Michael J.; Helps, Chris R.; School of Clinical Veterinary Science, University of Bristol, Langford, Bristol BS40 5DU, United Kingdom; School of Clinical Veterinary Science, University of Bristol, Langford, Bristol BS40 5DU, United Kingdom; School of Clinical Veterinary Science, University of Bristol, Langford, Bristol BS40 5DU, United Kingdom; School of Clinical Veterinary Science, University of Bristol, Langford, Bristol BS40 5DU, United Kingdom; Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland; Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland; School of Clinical Veterinary Science, University of Bristol, Langford, Bristol BS40 5DU, United Kingdom; School of Clinical Veterinary Science, University of Bristol, Langford, Bristol BS40 5DU, United Kingdom; School of Clinical Veterinary Science, University of Bristol, Langford, Bristol BS40 5DU, United Kingdom; School of Clinical Veterinary Science, University of Bristol, Langford, Bristol BS4; (Veterinary microbiology, v.139, 2009, pp.323-332)
16
QUICK MENU
